Toggle light / dark theme

The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy

Posted in biotech/medical

A recent Science Immunology Review suggests combining inhibitory strategies, such as ICI, alongside radiotherapy may counteract the creation of immunosuppressive adenosine during Cancer immunotherapy.

Learn more on.


Adenosine generation is a rheostat of DNA damage-induced immune signaling in the tumor microenvironment.